Highlights:
* Althea Concierge UK launched successfully with doctors already commencing 
their first assessments of patients for Althea medical cannabis products
* Althea Concierge UK streamlines the prescription process and facilitates 
patient referrals from primary care doctors to Althea UK specialist prescribers
* Althea and Drug Science joint educational meetings to be held in June are 
oversubscribed, with nearly 300 healthcare professionals registered to attend
* Althea sponsored and participated in the recent IOTOD conference in Germany

United Kingdom, 31 May 2019: Australian medicinal cannabis company Althea Group 
Holdings Limited (ASX: AGH), through its wholly-owned subsidiary, Althea MMJ UK 
Ltd ('Althea' or 'the Company'), is pleased to announce the launch of Althea 
Concierge UK and the progression of its partnerships with Drug Science and the 
Improving Outcomes in the Treatment of Opioid Dependence (IOTOD) scientific 
committees.

Please open the attachment provided to learn more ( 
http://journalists.medianet.com.au/DisplayAttachment.aspx?j=916461&s=2&k=4568738)


About Althea Group Holdings Limited (ASX:AGH)
Althea is an Australian licensed producer, supplier and exporter of 
pharmaceutical grade medicinal cannabis and is listed publicly on the 
Australian Securities Exchange (ASX:AGH). Althea also offers a range of 
education, access and management services to support eligible patients and 
healthcare professionals in navigating medicinal cannabis treatment pathways.

Althea currently operates within highly regulated medicinal cannabis markets 
including Australia and the United Kingdom, with plans to expand into emerging 
markets throughout Asia and Europe. To learn more, please visit: www.althea.life


SOURCE: Althea Group Holdings Limited (ASX:AGH)